Impaired resolution of inflammation in the Endoglin heterozygous mouse model of chronic colitis

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Peter, Madonna R ^a,b   Jerkic, Mirjana ^a,c   Sotov, Valentin ^a,b   Douda, David N ^a,b   Ardelean, Daniela S ^a,b   Ghamami, Niousha ^a   Lakschevitz, Flavia ^d   Khan, Meraj A ^a   Robertson, Susan J ^b   Glogauer, Michael ^d   Philpott, Dana J ^b   Palaniyar, Nades ^a,b   Letarte, Michelle ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CD79A ANTIGEN; CXCL1 CHEMOKINE; ENDOGLIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOLLISTATIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; THROMBOSPONDIN 1; ENDOGLIN PROTEIN, MOUSE; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; HAPLOINSUFFICIENCY; INFECTION SENSITIVITY; INTESTINE FLORA; LAMINA PROPRIA; MONOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; HETEROZYGOTE; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; CHEMOKINE CXCL1; COLITIS; DISEASE MODELS, ANIMAL; HETEROZYGOTE; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84904670334     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/767185     Document Type: Article

References (56)

1. Maloy K. J., Powrie F., Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011 474 7351 298 306 2-s2.0-79959271087 10.1038/nature10208
2. Nathan C., Ding A., Nonresolving inflammation. Cell 2010 140 6 871 882 2-s2.0-77950365906 10.1016/j.cell.2010.02.029
3. Chidlow J. H. Jr., Shukla D., Grisham M. B., Kevil C. G., Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. American Journal of Physiology-Gastrointestinal and Liver Physiology 2007 293 1 G5 G18 2-s2.0-34547116660 10.1152/ajpgi.00107.2007 (Pubitemid 47105158)
4. Deban L., Correale C., Vetrano S., Malesci A., Danese S., Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a jack of all trades. American Journal of Pathology 2008 172 6 1457 1466 2-s2.0-44849118823 10.2353/ajpath.2008.070593 (Pubitemid 351793339)
5. Valluru M., Staton C. A., Reed M. W. R., Brown N. J., Transforming growth factor- β and endoglin signaling orchestrate wound healing. Frontiers in Physiology 2011 2, article 89 2-s2.0-84863537139 10.3389/fphys.2011.00089
6. de Kretser D. M., O'Hehir R. E., Hardy C. L., Hedger M. P., The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Molecular and Cellular Endocrinology 2012 359 1-2 101 106 2-s2.0-84861653647 10.1016/j.mce.2011.10.009
7. ten Dijke P., Arthur H. M., Extracellular control of TGF β signalling in vascular development and disease. Nature Reviews Molecular Cell Biology 2007 8 11 857 869 2-s2.0-35448991324 10.1038/nrm2262 (Pubitemid 47622560)
8. Li M. O., Wan Y. Y., Sanjabi S., Robertson A.-K. L., Flavell R. A., Transforming growth factor- β regulation of immune responses. Annual Review of Immunology 2006 24 99 146 2-s2.0-33646164362 10.1146/annurev.immunol.24. 021605.090737
9. Barbara N. P., Wrana J. L., Letarte M., Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor- β superfamily. The Journal of Biological Chemistry 1999 274 2 584 594 2-s2.0-0033534572 10.1074/jbc.274.2.584 (Pubitemid 29058021)
10. Gougos A., Letarte M., Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. Journal of Immunology 1988 141 6 1925 1933 2-s2.0-0023784185
11. Castonguay R., Werner E. D., Matthews R. G., Presman E., Mulivor A. W., Solban N., Sako D., Pearsall R. S., Underwood K. W., Seehra J., Kumar R., Grinberg A. V., Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth. The Journal of Biological Chemistry 2011 286 34 30034 30046 2-s2.0-80051920312 10.1074/jbc.M111.260133
12. ten Dijke P., Goumans M.-J., Pardali E., Endoglin in angiogenesis and vascular diseases. Angiogenesis 2008 11 1 79 89 2-s2.0-41049094560 10.1007/s10456-008-9101-9
13. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCormick M. K., Pericak-Vance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M., Marchuk D. A., Endoglin, a TGF- β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics 1994 8 4 345 351 2-s2.0-0028171579 10.1038/ng1294-345
14. Pece N., Vera S., Cymerman U., White R. I. Jr., Wrana J. L., Letarte M., Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. The Journal of Clinical Investigation 1997 100 10 2568 2579 2-s2.0-0030781148 (Pubitemid 27514897)
15. Lastres P., Bellon T., Cabañas C., Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. European Journal of Immunology 1992 22 2 393 397 2-s2.0-0026599008
16. Rokhlin O. W., Cohen M. B., Kubagawa H., Letarte M., Cooper M. D., Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. Journal of Immunology 1995 154 9 4456 4465 2-s2.0-0029035687
17. St-Jacques S., Cymerman U., Pece N., Letarte M., Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor- β binding protein of endothelial and stromal cells. Endocrinology 1994 134 6 2645 2657 2-s2.0-0028231917 10.1210/en.134.6. 2645 (Pubitemid 24170882)
18. Dupuis-Girod S., Giraud S., Decullier E., Lesca G., Cottin V., Faure F., Merrot O., Saurin J.-C., Cordier J.-F., Plauchu H., Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clinical Infectious Diseases 2007 44 6 841 845 2-s2.0-33847620295 10.1086/511645 (Pubitemid 46365311)
19. Mathis S., Dupuis-Girod S., Plauchu H., Giroud M., Barroso B., Ly K. H., Ingrand P., Gilbert B., Godenche G., Neau J.-P., Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clinical Neurology and Neurosurgery 2012 114 3 235 240 2-s2.0-84857788210 10.1016/j.clineuro.2011.10.036
20. + precursors. Blood 2001 98 13 3635 3642 2-s2.0-0035895073 10.1182/blood.V98.13.3635
21. van Laake L. W., Van Den Driesche S., Post S., Feijen A., Jansen M. A., Driessens M. H., Mager J. J., Snijder R. J., Westermann C. J. J., Doevendans P. A., Van Echteld C. J. A., Ten Dijke P., Arthur H. M., Goumans M.-J., Lebrin F., Mummery C. L., Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006 114 21 2288 2297 2-s2.0-33751209183 10.1161/CIRCULATIONAHA.106.639161 (Pubitemid 44789503)
22. Bourdeau A., Dumont D. J., Letarte M., A murine model of hereditary hemorrhagic telangiectasia. The Journal of Clinical Investigation 1999 104 10 1343 1351 2-s2.0-0032720393
23. Bourdeau A., Faughnan M. E., McDonald M.-L., Paterson A. D., Wanless I. R., Letarte M., Potential role of modifier genes influencing transforming growth factor- β 1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. American Journal of Pathology 2001 158 6 2011 2020 2-s2.0-0034970744 (Pubitemid 32545187)
24. Jerkic M., Rivas-Elena J. V., Prieto M., Carrón R., Sanz-Rodríguez F., Pérez-Barriocanal F., Rodríguez-Barbero A., Bernabéu C., López-Novoa J. M., Endoglin regulates nitric oxide-dependent vasodilatation. The FASEB Journal 2004 18 3 609 611 2-s2.0-2442700619
25. Jerkic M., Peter M., Ardelean D., Fine M., Konerding M. A., Letarte M., Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in endoglin heterozygous mice. Inflammatory Bowel Diseases 2010 16 11 1859 1870 2-s2.0-78249232956 10.1002/ibd.21288
26. Lopez-Dee Z., Pidcock K., Gutierrez L. S., Thrombospondin-1: multiple paths to inflammation. Mediators of Inflammation 2011 2011 10 2-s2.0-80052333271 10.1155/2011/296069 296069
27. Heinke J., Wehofsits L., Zhou Q., Zoeller C., Baar K.-M., Helbing T., Laib A., Augustin H., Bode C., Patterson C., Moser M., BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circulation Research 2008 103 8 804 812 2-s2.0-54449100051 10.1161/CIRCRESAHA. 108.178434
28. Helbing T., Rothweiler R., Ketterer E., Goetz L., Heinke J., Grundmann S., Duerschmied D., Patterson C., Bode C., Moser M., BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium. Blood 2011 118 18 5040 5049 2-s2.0-80855128771 10.1182/blood-2011-03-339762
29. Weigmann B., Tubbe I., Seidel D., Nicolaev A., Becker C., Neurath M. F., Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nature Protocols 2007 2 10 2307 2311 2-s2.0-38449084962 10.1038/nprot.2007.315
30. Barman M., Unold D., Shifley K., Amir E., Hung K., Bos N., Salzman N., Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infection and Immunity 2008 76 3 907 915 2-s2.0-40749084834 10.1128/IAI.01432-07 (Pubitemid 351428049)
31. Petnicki-Ocwieja T., Hrncir T., Liu Y.-J., Biswas A., Hudcovic T., Tlaskalova-Hogenova H., Kobayashi K. S., Nod2 is required for the regulation of commensal microbiota in the intestine. Proceedings of the National Academy of Sciences of the United States of America 2009 106 37 15813 15818 2-s2.0-70349468054 10.1073/pnas.0907722106
32. Furet J.-P., Firmesse O., Gourmelon M., Bridonneau C., Tap J., Mondot S., Doré J., Corthier G., Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiology Ecology 2009 68 3 351 362 2-s2.0-65549150087 10.1111/j.1574-6941.2009.00671.x
33. Kanwar S., Kubes P., Mast cells contribute to ischemia-reperfusion- induced granulocyte infiltration and intestinal dysfunction. American Journal of Physiology 1994 267 2, part 1 G316 G321 2-s2.0-0028150140
34. Jerkic M., Sotov V., Letarte M., Oxidative stress contributes to endothelial dysfunction in mouse models of hereditary hemorrhagic telangiectasia. Oxidative Medicine and Cellular Longevity 2012 2012 9 2-s2.0-84872769668 10.1155/2012/686972 686972
35. Sun C. X., Downey G. P., Zhu F., Koh A. L. Y., Thang H., Glogauer M., Rac1 is the small GTPase responsible for regulating the neutrophil chemotaxis compass. Blood 2004 104 12 3758 3765 2-s2.0-9444238519 10.1182/blood-2004-03- 0781 (Pubitemid 39564455)
36. Perše M., Cerar A., Dextran sodium sulphate colitis mouse model: traps and tricks. Journal of Biomedicine and Biotechnology 2012 2012 13 2-s2.0-84862297537 10.1155/2012/718617 718617
37. Zhang Y.-Q., Resta S., Jung B., Barrett K. E., Sarvetnick N., Upregulation of activin signaling in experimental colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2009 297 4 G768 G780 2-s2.0-70349743989 10.1152/ajpgi.90631.2008
38. Li J. L., Ng L. G., Peeking into the secret life of neutrophils. Immunologic Research 2012 53 1-3 168 181 10.1007/s12026-012-8292-8
39. Segal A. W., How neutrophils kill microbes. Annual Review of Immunology 2005 23 197 223 2-s2.0-17644377258 10.1146/annurev.immunol.23.021704.115653 (Pubitemid 40563169)
40. Stolk J., Hiltermann T. J., Dijkman J. H., Verhoeven A. J., Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. American Journal of Respiratory Cell and Molecular Biology 1994 11 1 95 102 2-s2.0-0028473441
41. Frangogiannis N. G., Ren G., Dewald O., Zymek P., Haudek S., Koerting A., Winkelmann K., Michael L. H., Lawler J., Entman M. L., Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005 111 22 2935 2942 2-s2.0-20444489650 10.1161/CIRCULATIONAHA.104.510354 (Pubitemid 40814186)
42. Frangogiannis N. G., Regulation of the inflammatory response in cardiac repair. Circulation Research 2012 110 1 159 173 2-s2.0-84855371090 10.1161/CIRCRESAHA.111.243162
43. Krishna S. M., Golledge J., The role of thrombospondin-1 in cardiovascular health and pathology. International Journal of Cardiology 2013 168 2 692 706 2-s2.0-84876961818 10.1016/j.ijcard.2013.04.139
44. Ardelean D. S., Jerkic M., Yin M., Peter M., Ngan B., Kerbel R. S., Foster F. S., Letarte M., Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. Angiogenesis 2014 17 1 129 146 10.1007/s10456-013-9383-4
45. Park S., Dimaio T. A., Liu W., Wang S., Sorenson C. M., Sheibani N., Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF- β signaling pathways. Journal of Cell Science 2013 126, part 6 1392 1405 2-s2.0-84877890780 10.1242/jcs.117275
46. Hedger M. P., Winnall W. R., Phillips D. J., de Kretser D. M., The regulation and functions of activin and follistatin in inflammation and immunity. Vitamins and Hormones 2011 85 255 297 2-s2.0-79951898907 10.1016/B978-0-12-385961-7.00013-5
47. Dohi T., Ejima C., Kato R., Kawamura Y. I., Kawashima R., Mizutani N., Tabuchi Y., Kojima I., Therapeutic potential of follistatin for colonic inflammation in mice. Gastroenterology 2005 128 2 411 423 2-s2.0-14944365560 10.1053/j.gastro.2004.11.063 (Pubitemid 40431093)
48. Moser M., Binder O., Wu Y., Aitsebaomo J., Ren R., Bode C., Bautch V. L., Conlon F. L., Patterson C., BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Molecular and Cellular Biology 2003 23 16 5664 5679 2-s2.0-0043133835 10.1128/MCB.23.16.5664-5679.2003 (Pubitemid 36951331)
49. Yao Y., Jumabay M., Ly A., Radparvar M., Wang A. H., Abdmaulen R., Boström K. I., Crossveinless 2 regulates bone morphogenetic protein 9 in human and mouse vascular endothelium. Blood 2012 119 21 5037 5047 2-s2.0-84861495270 10.1182/blood-2011-10-385906
50. Mehrad B., Keane M. P., Strieter R. M., Chemokines as mediators of angiogenesis. Thrombosis and Haemostasis 2007 97 5 755 762 2-s2.0-34249066312 10.1160/TH07-01-0040 (Pubitemid 46804315)
51. Miyake M., Goodison S., Urquidi V., Gomes Giacoia E., Rosser C. J., Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Laboratory Investigation 2013 93 7 768 778 2-s2.0-84879668186 10.1038/labinvest.2013.71
52. Ardelean D. S., Yin M., Jerkic M., Peter M., Ngan B., Kerbel R. S., Foster F. S., Letarte M., Anti-VEGF therapy reduces intestinal inflammation in Endoglin heterozygous mice subjected to experimental colitis. Angiogenesis 2014 17 3 641 659 10.1007/s10456-014-9421-x
53. Li E., Hamm C. M., Gulati A. S., Sartor R. B., Chen H., Wu X., Zhang T., Rohlf F. J., Zhu W., Gu C., Robertson C. E., Pace N. R., Boedeker E. C., Harpaz N., Yuan J., Weinstock G. M., Sodergren E., Frank D. N., Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS ONE 2012 7 6 2-s2.0-84861001724 10.1371/journal.pone.0026284 e26284
54. Rahman F. Z., Marks D. J. B., Hayee B. H., Smith A. M., Bloom S. L., Segal A. W., Phagocyte dysfunction and inflammatory bowel disease. Inflammatory Bowel Diseases 2008 14 10 1443 1452 2-s2.0-59749090982 10.1002/ibd.20449
55. Klebanoff S. J., Myeloperoxidase: friend and foe. Journal of Leukocyte Biology 2005 77 5 598 625 2-s2.0-18244390487 10.1189/jlb.1204697 (Pubitemid 40628741)
56. Ojeda-Fernandez L., Recio-Poveda L., Lastres P., Arthur H. M., Bernabeu C., Botella L. M., Characterization of a myeloid specific endoglin knock-out mouse: the role of endoglin in the innate immune response. Hematology Reports 2013 5 supplement 1 15